Best of the Week
Most Popular
1. The Trump Stock Market Trap May Be Triggered - Barry_M_Ferguson
2.Why are Central Banks Buying Gold and Dumping Dollars? - Richard_Mills
3.US China War - Thucydides Trap and gold - Richard_Mills
4.Gold Price Trend Forcast to End September 2019 - Nadeem_Walayat
5.Money Saving Kids Gardening Growing Giant Sunflowers Summer Fun - Anika_Walayat
6.US Dollar Breakdown Begins, Gold Price to Bolt Higher - Jim_Willie_CB
7.INTEL (INTC) Stock Investing to Profit From AI Machine Learning Boom - Nadeem_Walayat
8.Will Google AI Kill Us? Man vs Machine Intelligence - N_Walayat
9.US Prepares for Currency War with China - Richard_Mills
10.Gold Price Epochal Breakout Will Not Be Negated by a Correction - Clive Maund
Last 7 days
US Housing Market Real Terms BUY / SELL Indicator - 16th July 19
Could Trump Really Win the 2020 US Presidential Election? - 16th July 19
Gold Stocks Forming Bullish Consolidation - 16th July 19
Will Fed Easing Turn Out Like 1995 or 2007? - 16th July 19
Red Rock Entertainment Investments: Around the world in a day with Supreme Jets - 16th July 19
Silver Has Already Gone from Weak to Strong Hands - 15th July 19
Top Equity Mutual Funds That Offer Best Returns - 15th July 19
Gold’s Breakout And The US Dollar - 15th July 19
Financial Markets, Iran, U.S. Global Hegemony - 15th July 19
U.S Bond Yields Point to a 40% Rise in SPX - 15th July 19
Corporate Earnings may Surprise the Stock Market – Watch Out! - 15th July 19
Stock Market Interest Rate Cut Prevails - 15th July 19
Dow Stock Market Trend Forecast Current State July 2019 Video - 15th July 19
Why Summer is the Best Time to be in the Entertainment Industry - 15th July 19
Mid-August Is A Critical Turning Point For US Stocks - 14th July 19
Fed’s Recessionary Indicators and Gold - 14th July 19
The Problem with Keynesian Economics - 14th July 19
Stocks Market Investors Worried About the Fed? Don't Be -- Here's Why - 13th July 19
Could Gold Launch Into A Parabolic Upside Rally? - 13th July 19
Stock Market SPX and Dow in BREAKOUT but this is the worrying part - 13th July 19
Key Stage 2 SATS Tests Results Grades and Scores GDS, EXS, WTS Explained - 13th July 19
INTEL Stock Investing in Qubits and AI Neural Network Processors - Video - 12th July 19
Gold Price Selloff Risk High - 12th July 19
State of the US Economy as Laffer Gets Laughable - 12th July 19
Dow Stock Market Trend Forecast Current State - 12th July 19
Stock Market Major Index Top In 3 to 5 Weeks? - 11th July 19
Platinum Price vs Gold Price - 11th July 19
What This Centi-Billionaire Fashion Magnate Can Teach You About Investing - 11th July 19
Stock Market Fundamentals are Weakening: 3000 on SPX Means Nothing - 11th July 19
This Tobacco Stock Is a Big Winner from E-Cigarette Bans - 11th July 19
Investing in Life Extending Pharma Stocks - 11th July 19
How to Pay for It All: An Option the Presidential Candidates Missed - 11th July 19
Mining Stocks Flash Powerful Signal for Gold and Silver Markets - 11th July 19
5 Surefire Ways to Get More Viewers for Your Video Series - 11th July 19
Gold Price Gann Angle Update - 10th July 19
Crude Oil Prices and the 2019 Hurricane Season - 10th July 19
Can Gold Recover from Friday’s Strong Payrolls Hit? - 10th July 19
Netflix’s Worst Nightmare Has Come True - 10th July 19
LIMITLESS - Improving Cognitive Function and Fighting Brain Ageing Right Now! - 10th July 19
US Dollar Strength Will Drive Markets Higher - 10th July 19
Government-Pumped Student Loan Bubble Sets Up Next Financial Crisis - 10th July 19
Stock Market SPX 3000 Dream is Pushed Away: Pullback of 5-10% is Coming - 10th July 19
July 2019 GBPUSD Market Update and Outlook - 10th July 19

Market Oracle FREE Newsletter

Top AI Stocks Investing to Profit from the Machine Intelligence Mega-trend

Profit From Tech That Freezes Fat Away

Companies / Healthcare Sector Nov 13, 2014 - 05:35 PM GMT

By: Money_Morning

Companies

Michael A. Robinson writes: Five years ago, I quit drinking.

I did so not because I had a problem, but in order to shed some weight. And I was lucky – after I stopped drinking, the pounds just seemed to melt away.

I know most folks aren't that fortunate. That's why dieting and exercise in the United States is a $60.5 billion industry.


The party season surrounding Thanksgiving, Christmas, and New Year's is rapidly approaching, and so that weight-watching industry is just as quickly ramping up its marketing.

With that in mind, I found us a way to invest in this huge sector – and also stick with our mission to build wealth through technology.

And this company is in turnaround – setting us up with a "special situation" stock with the potential to double in three years…

Welcome to the New "Aesthetic Medicine"

Please – don't think I'm suggesting you invest in some new diet fad. Far from it.

The technology I want to tell you about involves a breakthrough medical device approved by the U.S. Food and Drug Administration, an agency that is always on the lookout for scams.

In fact, the company I have in mind successfully treated more than 4,000 patients during clinical trials.

It also has published more than 40 medical papers and abstracts on its science, which was developed at a teaching hospital affiliated with Harvard Medical School.

And besides the tens of billions of dollars we spend on weight loss each year, there's another number that demonstrates how large this company's market could eventually be.

According to the American Medical Association, more than 75 million Americans are obese. The condition causes a wide range of problems that can lead to premature death, including heart disease or diabetes.

And in addition to the obese, millions more of us are in pretty good shape but would just like to drop a few unsightly pounds. I know from experience that it's hard to get rid of love handles. For women, it's often the hips or thighs that bedevil them.

These are the kinds of cases tailor-made for what's known as "aesthetic medicine," a field that includes everything from plastic surgery to liposuction.

Forecasters at BCC Research estimate that aesthetic medicine is growing at an annual compound rate of 7.4% and should hit $4.8 billion by the end of next year.

Clearly, ZELTIQ Aesthetics Inc. (Nasdaq: ZLTQ) and other aesthetic medicine firms have a great opportunity to do well now and in the future. This growing medical tech firm uses controlled cooling to eliminate unwanted body fat in a nonsurgical, minimally invasive procedure known as Cryolipolysis.

How This New Tech Freezes Fat Away

That's a mouthful. So let me tell you about it.

Simply stated, ZELTIQ freezes away the fat. The company uses a cooling device to destroy fat cells. The device extracts energy from those cells without damaging other tissue.

Cryolipolysis also has no effect on a patient's skin, which means minimal recovery time and no sign of treatment.

Over the course of two to four months, the fat cells in the treated areas are gradually eliminated through the body's normal metabolic processes.

ZELTIQ's CoolSculpting system consists of a control unit and a number of applicators. ZELTIQ derives most of its revenue from sales of the CoolSculpting system and of the applicators doctors use to treat different sizes and shapes of fat bulges.

Additional sales stem from something the firm calls "cycles." These are specific-use procedure packs activated with the CoolSculpting machine. A cycle lasts about an hour, and patients typically need two "cycles" to treat for the arms and up to four to treat stomach fat.

If it executes against its plan, ZELTIQ will see a lot of growth. Based on U.S. Census data and its own consumer surveys, the company says it could hit $2 billion in sales over the next few years. In 2013, ZELTIQ had sales of $111.6 million.

ZELTIQ arrived at that $2 billion number after its surveys projected some 4 million Americans would be ready to receive treatment that would require four cycles at $125 each.

Going public in 2010 amid great excitement about its unique technology in a huge market, the company quickly stumbled. It racked up several quarters of losses, putting the stock under pressure.

To capitalize on its potential, ZELTIQ needed a strong corporate turnaround. And that's just what started happening in 2012 when the board of directors shook up the management team.
A Company Firmly in Turnaround

This is the pivotal event in the company's recent history. I've been involved with turnarounds since the early 1980s, and so I know that most of the successful ones require a new visionary leader who surrounds him- or herself with a talented team.

Mark Foley became president and chief executive officer of ZELTIQ in April 2012. He has more than 25 years of experience in the medical device industry, having served as an executive at several fast-growing startups later acquired by global firms.

In fall 2012, Foley brought in new managers to serve as chief technology officer, chief financial officer, head of worldwide sales and marketing, and vice president of operations.

Those appointments hailed from such medical tech leaders as NuVasive Inc. (Nasdaq: NUVA), Medtronic Inc. (NYSE: MDT), and Thoratec Corp. (Nasdaq: THOR).

Foley also split ZELTIQ's sales team in two. One sells the CoolSculpting equipment, and the other focuses on selling the supplies. ZELTIQ also holds teaching clinics for aesthetic medicine professionals so they give patients the best results – and lead to more referrals.

It's all starting to pay off.

In this year's third quarter, ZELTIQ smashed Wall Street's expectations. ZELTIQ was projected to lose $0.10 a share but actually earned $0.12. Sales climbed 55% to $45.7 million – more than 15% above analysts' forecasts.

With a market cap of roughly $1 billion, the stock trades at about $27.75. Profit margins and returns on equity remain weak, underscoring that this is a turnaround in progress.

But on the strength of its new strategic plan and recent profits, ZELTIQ is in a rally. It's up 50% in the past three months and is trading near a new high.

Yet, I still see plenty of upside ahead for this "special situation." If the company continues growing sales and earnings at anything close to its current rate, the stock could easily double in the next three years.

Of course, special situations like this belong in the higher risk portion of your portfolio.

But it doesn't take many stocks like ZELTIQ to really boost your net worth.

And during the holiday season, we could all use a little more worth in our pockets.

Source : http://moneymorning.com/2014/11/13/this-profit-doubling-companys-product-freezes-fat-away/

Money Morning/The Money Map Report

©2014 Monument Street Publishing. All Rights Reserved. Protected by copyright laws of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), of content from this website, in whole or in part, is strictly prohibited without the express written permission of Monument Street Publishing. 105 West Monument Street, Baltimore MD 21201, Email: customerservice@moneymorning.com

Disclaimer: Nothing published by Money Morning should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investent advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication, or after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended by Money Morning should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.

Money Morning Archive

© 2005-2019 http://www.MarketOracle.co.uk - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.


Post Comment

Only logged in users are allowed to post comments. Register/ Log in

6 Critical Money Making Rules